Elisabetta Ferrante
Elisabetta Ferrante publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine, on topics such as Antiplatelet Therapy and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management and Atrial Fibrillation Management and Outcomes.
- World rank
- #2,230,373 of 7,710,434 ranked researchers
- Rank in United States
- #668,019 of 1,627,098
- Works
- 30
- Citations
- 1k
- Citations per work
- 34.2
What does Elisabetta Ferrante research?
Elisabetta Ferrante's work is mostly in Medicine (81%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2480.6%
- Medicine2480.6%
- Everything else619.4%
- 1Cardiology and Cardiovascular Medicine48% of their works
- 2Surgery10% of their works
- 3Internal Medicine8% of their works
- 4Pharmacology6% of their works
- 5Endocrinology, Diabetes and Metabolism5% of their works
- 6Hematology4% of their works
Research topics
- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Inflammatory mediators and NSAID effects
- Lipoproteins and Cardiovascular Health
- Diabetes Treatment and Management
- Advanced Glycation End Products research
Which keywords describe Elisabetta Ferrante's research?
The keywords of their largest research topics: Aspirin, Clopidogrel, Guidelines, Antithrombotic Therapy, Inflammation, Venous Thromboembolism, Acute Coronary Syndromes and Anticoagulant Therapy.
- HMGB1
- Type 2 Diabetes
- Statins
- Cyclooxygenase-2 Inhibitors
- Myocardial Infarction
- Anticoagulant Therapy
- Venous Thromboembolism
- Antithrombotic Therapy
- Clopidogrel
- Aspirin
- Guidelines
- Inflammation
- Acute Coronary Syndromes
- Atrial Fibrillation
- Cancer
- Cholesterol-lowering
- Cardiovascular Outcomes
- Advanced Glycation End Products
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Aspirin261 topic
- Clopidogrel261 topic
- Guidelines122 topics
- Antithrombotic Therapy71 topic
- Inflammation72 topics
- Venous Thromboembolism71 topic
- Acute Coronary Syndromes61 topic
- Anticoagulant Therapy61 topic
- Atrial Fibrillation61 topic
- Myocardial Infarction61 topic
- Cancer51 topic
- Cyclooxygenase-2 Inhibitors51 topic
- Cholesterol-lowering41 topic
- Statins41 topic
- Cardiovascular Outcomes31 topic
- Type 2 Diabetes31 topic
- Advanced Glycation End Products21 topic
- HMGB121 topic
Where does Elisabetta Ferrante work?
Elisabetta Ferrante's main affiliation in the publication record is Florida College, United States.
How many publications and citations does Elisabetta Ferrante have?
OpenAlex counts 30 works and 1,026 citations for Elisabetta Ferrante, an h-index of 13, ranking #2,230,373 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Elisabetta Ferrante. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.